Galderma SA:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Galderma SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3317
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:36
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Galderma SA (Galderma), a subsidiary of Nestle SA, is a pharmaceutical company that develops and markets drugs, medical dermatology solutions and therapeutic skin care products for the treatment of hair, nail, and skin diseases. Galderma offers products for the treatment of skin conditions such as seborrheic dermatitis, dry skin, acne, psoriasis, atopic dermatitis, steroid responsive dermatoses, pigmentation disorders, aging skin, onychomycosis, rosacea, skin cancer and others. The company offers products leading brands such as Azzalure, Cetaphil, Clobex, Macrolane, and Oracea among several others. It markets products in India, Greece, Italy, Canada, Chile, Poland, the UK, and the US, among others. The company operates manufacturing facilities in France, Sweden, Canada, Brazil, Germany and Switzerland and research and development (R&D) centers in France, Sweden, the US, Switzerland and Japan. Galderma is headquartered in Lausanne, Switzerland.

Galderma SA – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Galderma SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Galderma SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Galderma SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Galderma SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Galderma SA, Medical Devices Deals, 2012 to YTD 2018 9
Galderma SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Galderma SA, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Galderma to Acquire Assets of Laboratoires Inneov from L’Oreal 11
Galderma Completes Acquisition of Aesthetic Dermatology Assets from Valeant Pharma for USD1.4 Billion 12
Galderma Acquires Pekiron Cream From Kyorin Pharma 13
Partnerships 14
Galderma Enters into Research Agreement with Icahn School of Medicine at Mount Sinai and Northwestern University Feinberg School of Medicine 14
Bioventus Enters into Agreement with Galderma for Durolane in US 15
Galderma Enters into Distribution Agreement with Ipsen for Dysport in Asia-Pacific 16
Galderma Enters into Agreement with ZELTIQ Aesthetics 17
Galderma Enters into Agreement with ImaBiotech 18
Ipsen Extends Distribution Agreement with Galderma for Dysport 19
Ipsen Extends Distribution Agreement With Galderma For Dysport 21
Sinclair IS Pharma Enters Into Co-Promotion Agreement With Galderma For Kelo-cote 22
Licensing Agreements 23
Clementia Pharma Enters into Licensing Agreement with Galderma R&D 23
Galderma Pharma Enters into Licensing Agreement with Chugai Pharma 24
Nuvo Research Enters into Licensing Agreement with Galderma Pharma for Pliaglis 25
Asset Transactions 26
Bioventus Acquires Durolane Assets From Galderma 26
Onset Dermatologics Acquires Worldwide Rights To Clindagel From Galderma Labs 27
STADA Arzneimittel Completes Acquisition Of Generics Business From Spirig Pharma For US$108 Million 28
Acquisition 29
Nestle Completes Acquisition of Remaining 50% Stake in Galderma for USD3.5 Billion 29
Galderma Pharma Acquires Spirig Pharma 30
Galderma SA – Key Competitors 31
Galderma SA – Key Employees 32
Galderma SA – Locations And Subsidiaries 33
Head Office 33
Other Locations & Subsidiaries 33
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36

List of Tables
Galderma SA, Pharmaceuticals & Healthcare, Key Facts 2
Galderma SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Galderma SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Galderma SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Galderma SA, Deals By Therapy Area, 2012 to YTD 2018 8
Galderma SA, Medical Devices Deals, 2012 to YTD 2018 9
Galderma SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Galderma to Acquire Assets of Laboratoires Inneov from L'Oreal 11
Galderma Completes Acquisition of Aesthetic Dermatology Assets from Valeant Pharma for USD1.4 Billion 12
Galderma Acquires Pekiron Cream From Kyorin Pharma 13
Galderma Enters into Research Agreement with Icahn School of Medicine at Mount Sinai and Northwestern University Feinberg School of Medicine 14
Bioventus Enters into Agreement with Galderma for Durolane in US 15
Galderma Enters into Distribution Agreement with Ipsen for Dysport in Asia-Pacific 16
Galderma Enters into Agreement with ZELTIQ Aesthetics 17
Galderma Enters into Agreement with ImaBiotech 18
Ipsen Extends Distribution Agreement with Galderma for Dysport 19
Ipsen Extends Distribution Agreement With Galderma For Dysport 21
Sinclair IS Pharma Enters Into Co-Promotion Agreement With Galderma For Kelo-cote 22
Clementia Pharma Enters into Licensing Agreement with Galderma R&D 23
Galderma Pharma Enters into Licensing Agreement with Chugai Pharma 24
Nuvo Research Enters into Licensing Agreement with Galderma Pharma for Pliaglis 25
Bioventus Acquires Durolane Assets From Galderma 26
Onset Dermatologics Acquires Worldwide Rights To Clindagel From Galderma Labs 27
STADA Arzneimittel Completes Acquisition Of Generics Business From Spirig Pharma For US$108 Million 28
Nestle Completes Acquisition of Remaining 50% Stake in Galderma for USD3.5 Billion 29
Galderma Pharma Acquires Spirig Pharma 30
Galderma SA, Key Competitors 31
Galderma SA, Key Employees 32
Galderma SA, Other Locations 33
Galderma SA, Subsidiaries 33

List of Figures
Galderma SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Galderma SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Galderma SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Galderma SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Galderma SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Galderma SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Galderma SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Galderma SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Galderma SA, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Galderma SA:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Aviakompaniya Sibir” OAO (P):企業の戦略・SWOT・財務情報
    Aviakompaniya Sibir'' OAO (P) - Strategy, SWOT and Corporate Finance Report Summary Aviakompaniya Sibir'' OAO (P) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Mitsubishi Chemical Corp:企業の戦略的SWOT分析
    Mitsubishi Chemical Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • CSE Global Limited (544):企業の財務・戦略的SWOT分析
    CSE Global Limited (544) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Valneva SE (VLA):企業の財務・戦略的SWOT分析
    Valneva SE (VLA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Zargon Oil & Gas Ltd (ZAR):石油・ガス:M&Aディール及び事業提携情報
    Summary Zargon Oil & Gas Ltd (Zargon) is an upstream energy company. It carries out the exploration, development and production of oil and natural gas. The company’s core business is oil exploitation in the Western Canadian and Williston sedimentary basins. The company also specializes in all three …
  • Arqvia Group Ltd:企業の戦略・SWOT・財務分析
    Arqvia Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Arqvia Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Westinghouse Air Brake Technologies Corp:企業の戦略・SWOT・財務分析
    Westinghouse Air Brake Technologies Corp - Strategy, SWOT and Corporate Finance Report Summary Westinghouse Air Brake Technologies Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Sto SE & Co KGaA:企業の戦略・SWOT・財務情報
    Sto SE & Co KGaA - Strategy, SWOT and Corporate Finance Report Summary Sto SE & Co KGaA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Commonwealth Scientific and Industrial Research Organisation-医療機器分野:企業M&A・提携分析
    Summary Commonwealth Scientific and Industrial Research Organisation (CSIRO) is a national science agency that conducts research in climate adaptation, bio-security, renewable and energy, farming and food production, and information technology, and mining and manufacturing services, and others. The …
  • Avaya Inc.:企業の戦略・SWOT・財務情報
    Avaya Inc. - Strategy, SWOT and Corporate Finance Report Summary Avaya Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Eesti Energia AS:戦略・SWOT・企業財務分析
    Eesti Energia AS - Strategy, SWOT and Corporate Finance Report Summary Eesti Energia AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • First Interstate BancSystem, Inc.:企業の戦略・SWOT・財務情報
    First Interstate BancSystem, Inc. - Strategy, SWOT and Corporate Finance Report Summary First Interstate BancSystem, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • 3I Group Plc
    3I Group Plc - Strategy, SWOT and Corporate Finance Report Summary 3I Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Noble Corporation Plc (NE):企業の財務・戦略的SWOT分析
    Noble Corporation Plc (NE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Antisense Therapeutics Ltd (ANP):製薬・医療:M&Aディール及び事業提携情報
    Summary Antisense Therapeutics Ltd (Antisense Therapeutics) is clinical staged biopharmaceutical company which focuses on the discovery, development and commercialization of second generation antisense pharmaceuticals for various medical conditions that have large unmet medical needs. It focuses on …
  • AviAlliance GmbH:企業の戦略・SWOT・財務情報
    AviAlliance GmbH - Strategy, SWOT and Corporate Finance Report Summary AviAlliance GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Boralex Inc (BLX)-エネルギー分野:企業M&A・提携分析
    Summary Boralex Inc. (Boralex) is a renewable energy company that develops, constructs, and operates power plants. It produces electricity from wind, solar, hydro, natural gas, and wood residue sources; and sells that energy through long-term contracts. Boralex sources wood residues such as bark, wo …
  • Hewlett Packard Enterprise Company:戦略・SWOT・企業財務分析
    Hewlett Packard Enterprise Company - Strategy, SWOT and Corporate Finance Report Summary Hewlett Packard Enterprise Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Addison Lee Group:企業の戦略的SWOT分析
    Addison Lee Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • East Kentucky Power Cooperative Inc:企業の戦略的SWOT分析
    East Kentucky Power Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆